SecurityCSTR / CapStar Financial Holdings, Inc. (14070T102)
Institutional Owners58
Institutional Shares4,223,783 - 36.22%
Common Shares Outstanding11,660,457 shares (as of 2018-03-31)
Institutional Value$ 115,885,000 USD

Institutional Stock Ownership and Shareholders()

CSTR / CapStar Financial Holdings, Inc. Institutional Ownership

CapStar Financial Holdings, Inc. (NASDAQ:CSTR) has 58 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 4,223,783 shares. Largest shareholders include Corsair Capital LLC, BlackRock Inc., Wellington Management Group LLP, Vanguard Group Inc, Foresters Investment Management Company, Inc., Elizabeth Park Capital Advisors, Ltd., Banc Funds Co Llc, Ranger Investment Management, L.P., Penn Capital Management Co Inc, and Hennessy Advisors Inc.
CapStar Financial Holdings, Inc. (NASDAQ:CSTR) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/cstr"><img src="https://images.fintel.io/us-cstr-so.png" alt="CSTR / CapStar Financial Holdings, Inc. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-10 13F-HR JP Morgan Chase & Co 1,857 1,791 -3.55 39 34 -12.82
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 40,629 55,820 37.39 843 1,051 24.67
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 1,063 494 -53.53 22 9 -59.09
2017-02-10 13F-HR BlackRock Fund Advisors 89,311 1,961
2018-07-20 13F-HR HENNESSY ADVISORS INC 205,000 160,000 -21.95 3,860 2,965 -23.19
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 457 512 12.04 9 9 0.00
2018-04-13 13F-HR American Investment Services, Inc. 10,000 10,000 0.00 208 188 -9.62
2018-04-12 13F-HR Valeo Financial Advisors, Llc 1,400 1,400 0.00 29 26 -10.34
2018-05-15 13F-HR UBS Group AG 1,466 0 -100.00 30 0 -100.00
2018-05-15 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 2,570 48
2018-05-04 13F-HR Trustcore Financial Services, Llc 27,118 26,983 -0.50 563 508 -9.77
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 9,200 9,200 0.00 191 173 -9.42
2018-05-14 13F-HR MORGAN STANLEY 18,574 19,894 7.11 385 375 -2.60
2018-05-17 13F-HR Legal & General Group Plc 1,630 1,630 0.00 34 31 -8.82
2018-04-20 13F-HR STRS OHIO 200 200 0.00 4 3 -25.00
2018-05-07 13F-HR AMERICAN INTERNATIONAL GROUP INC 5,803 5,683 -2.07 121 107 -11.57
2018-05-15 13F-HR BARCLAYS PLC 1,571 1,843 17.31 32 35 9.38
2018-05-15 13F-HR Ranger Investment Management, L.P. 147,911 184,381 24.66 3,072 3,472 13.02
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 17,940 13,325 -25.72 372 251 -32.53
2017-02-10 13F-HR BlackRock Investment Management, LLC 1,008 22
2018-05-14 13F-HR Huber Capital Management LLC 147,439 149,108 1.13 3,062 2,808 -8.30
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA 1,972 1,919 -2.69 40,958 36,135 -11.78
2018-05-14 13F-HR ALLIANCEBERNSTEIN L.P. 21,570 84,802 293.15 448 1,597 256.47
2018-04-18 13F-HR SHAYNE & CO., LLC 20,023 21,273 6.24 416 401 -3.61
2018-05-07 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 15,100 15,100 0.00 314 285 -9.24
2018-05-14 13F-HR TEACHERS ADVISORS INC 14,854 14,854 0.00 309 280 -9.39
2018-05-15 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 13,940 13,940 0.00 290 262 -9.66
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 11,813 12,261 3.79 246 231 -6.10
2018-05-09 13F-HR BlackRock Inc. 388,842 388,553 -0.07 8,077 7,317 -9.41
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 3,378 74
2018-05-09 13F-HR NORTHERN TRUST CORP 90,444 89,844 -0.66 1,879 1,692 -9.95
2018-05-15 13F-HR STATE STREET CORP 88,283 95,813 8.53 1,833 1,806 -1.47
2018-05-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 21,079 21,079 0.00 438 397 -9.36
2018-05-11 13F-HR FORESTERS INVESTMENT MANAGEMENT COMPANY, INC. 228,500 290,500 27.13 4,746 5,470 15.25
2018-04-23 13F-HR FIRST TRUST ADVISORS LP 13,695 13,284 -3.00 284 250 -11.97
2018-05-09 13F-HR Corsair Capital LLC 665,313 665,313 0.00 13,819 12,528 -9.34
2018-05-11 13F-HR Harbor Advisors LLC 10,000 10,000 0.00 208 188 -9.62
2017-02-10 13F-HR BlackRock Advisors LLC 1,440 32
2018-05-11 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 29,078 26,182 -9.96 605 494 -18.35
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 1,302 0 -100.00 27 0 -100.00
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 6,252 6,428 2.82 130 121 -6.92
2018-05-11 13F-HR PENN CAPITAL MANAGEMENT CO INC 226,514 175,696 -22.43 4,705 3,308 -29.69
2018-05-11 13F-HR Russell Investments Group, Ltd. 52,182 56,176 7.65 1,114 1,058 -5.03
2018-04-16 13F-HR Raymond James Financial Services Advisors, Inc. 20,450 22,050 7.82 425 415 -2.35
2018-05-11 13F-HR STIFEL FINANCIAL CORP 32,198 31,604 -1.84 670 595 -11.19
2018-05-11 13F-HR BANC FUNDS CO LLC 275,400 275,400 0.00 5,720,058 5,186 -99.91
2018-05-15 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 51,550 56,400 9.41 1,071 1,062 -0.84
2018-05-11 13F-HR DIMENSIONAL FUND ADVISORS LP 43,419 818
2018-05-15 13F-HR VANGUARD GROUP INC 291,300 298,738 2.55 6,050 5,626 -7.01
2018-05-14 13F-HR NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 2,500 5,000 100.00 52 94 80.77
2018-05-15 13F-HR Bank of New York Mellon Corp 28,450 30,198 6.14 591 569 -3.72
2018-05-11 13F-HR Elizabeth Park Capital Advisors, Ltd. 283,595 283,595 0.00 5,890 5,340 -9.34
2018-06-01 13F-HR Diversified Trust Co 20,000 20,000 0.00 415 377 -9.16
2018-05-15 13F-HR Ameritas Investment Partners, Inc. 756 756 0.00 16 14 -12.50
2018-04-12 13F-HR ACADIAN ASSET MANAGEMENT LLC 2,622 5,570 112.43 54 105 94.44
2018-05-15 13F-HR DEUTSCHE BANK AG\ 19,498 10,752 -44.86 402 200 -50.25
2018-05-14 13F-HR WOODMONT INVESTMENT COUNSEL LLC 38,000 28,000 -26.32 789 527 -33.21
2018-05-15 13F-HR Wellington Management Group LLP 346,947 358,358 3.29 7,206 6,748 -6.36
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 8,910 9,550 7.18 185 180 -2.70
2018-05-11 13F-HR CITIGROUP INC 1,157 1,405 21.43 24 27 12.50

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

Bank of the Ozarks (OZRK) Q2 Earnings in Line, Costs Rise

2018-07-12 zacks
Bank of the Ozarks Inc.’s (OZRK - Free Report) second-quarter 2018 earnings per share of 89 cents came in line with the Zacks Consensus Estimate of 89 cents. The reported figure represents year-over-year growth of 21.9%. Results primarily benefited from an improvement in net interest income. Also, loans and deposit balances improved, which supported results to some extent. However, elevated expenses, lower non-interest income and higher provisions were the undermining factors. (1-0)

4 Reasons to Invest in Community Trust (CTBI) Stock Now

2018-07-05 zacks
Driven by strength in fundamentals and good growth prospects, Community Trust Bancorp, Inc. (CTBI - Free Report) looks like a solid investment option right now. Further, the company has been witnessing upward earnings estimate revisions off late, reflecting that analysts are optimistic about its earnings growth potential. The company’s Zacks Consensus Estimate for the current-year earnings has been revised 1.

Ameris (ABCB) Completes Hamilton State Bancshares Merger

2018-07-03 zacks
Ameris Bancorp (ABCB - Free Report) recently completed the acquisition of Hamilton State Bancshares, Inc., in an effort to expand into the Atlanta markets. Consequently, Hamilton State Bank, the banking subsidiary of Hamilton has been merged with Ameris’ subsidiary, Ameris Bank. Hamilton, with nearly $1.8 billion in assets, conducted its operations through almost 28 banking locations. At the time of the announcement of the deal, Edwin W. (2-0)

4 Reasons to Invest in Fidelity Southern (LION) Stock Now

2018-06-28 zacks
An improving operating backdrop, a rising-rate environment and easing of regulations, along with the strengthening of the domestic economy, should keep aiding banking stocks. So, we bring one such stock — Fidelity Southern Corporation (LION - Free Report) — which, based on its strong fundamentals and improving prospects, is a good investment option right now. The company’s Zacks Consensus Estimate for current-year earnings has been revised 3. (19-0)

3 Reasons to Invest in First BanCorp (FBP) Stock Right Now

2018-06-13 zacks
Given that the banking industry remains well positioned for growth, driven by the Fed rate hikes and the benefits from the gradually stabilizing operating environment, we think that it is a wise idea to add a few stocks from that industry to your portfolio now. Based on its underlying strength and good growth prospects, First BanCorp. (FBP - Free Report) stock seems to be a solid bet now. The company’s Zacks Consensus Estimate for current-year earnings has been revised 32. (27-0)

CUSIP: 14070T102